24 November 2017
News and Views
Links and Services
Sustained virologic response reduces risk of all-cause mortality in patients with HCV, finds this month's Clinical Gastroenterology & Hepatology.
The effectiveness of hepatitis C virus (HCV) treatment with pegylated interferon and ribavirin us
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors